Biologics have revolutionized the treatment of rheumatoid arthritis (RA) in recent years. However. data from clinical trials and actual clinical practice have shown that biologics currently in use may constitute a risk factor for reactivation of tuberculosis (TB) in patients with latent TB infection. Therefore. https://jalyttlers.shop/product-category/desk-lamp/